Patent ID: 11925618
Assignee: PIRAMAL ENTERPRISES LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A pharmaceutical kit for use in a combination therapy with an antioxidant enzyme inhibitor in the treatment of head and neck cancer, lung cancer, gastrointestinal cancer, blood and/or lymphatic system cancer, or breast cancer, the kit comprising:
1) the cyclin-dependent kinase (CDK) inhibitor voruciclib,
2) the antioxidant enzyme inhibitor, and
3) a package insert,
wherein the package insert comprises instructions for administering voruciclib in combination with the antioxidant enzyme inhibitor for the treatment of head and neck cancer, lung cancer, gastrointestinal cancer, blood and/or lymphatic system cancer, or breast cancer in a subject in need thereof.